ID

14545

Beschreibung

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00766090

Link

https://clinicaltrials.gov/show/NCT00766090

Stichworte

  1. 20.04.16 20.04.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

20. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT00766090

Eligibility Asthma NCT00766090

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00766090
Criteria
Beschreibung

Criteria

clinical diagnosis of asthma
Beschreibung

asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
Beschreibung

fev1 reversibility after albuterol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0449261
UMLS CUI [2]
C0001927
fev1 between 40-85% predicted
Beschreibung

fev1

Datentyp

boolean

Alias
UMLS CUI [1]
C0748133
currently on short acting beta2 agonist therapy
Beschreibung

short-acting beta-2 agonist

Datentyp

boolean

Alias
UMLS CUI [1]
C1373132
key exclusion criteria:
Beschreibung

exclusion criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0680251
history of life threatening asthma
Beschreibung

history of life threatening asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
respiratory infection or oropharyngeal candidiasis
Beschreibung

respiratory infection or oropharyngeal candidiasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0035243
UMLS CUI [2]
C0919659
asthma exacerbation
Beschreibung

asthma exacerbation

Datentyp

boolean

Alias
UMLS CUI [1]
C0349790
uncontrolled disease or clinical abnormality
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
allergies
Beschreibung

allergies

Datentyp

boolean

Alias
UMLS CUI [1]
C0020517
taking another investigational medications or other prohibited medications
Beschreibung

another investigational medications or other prohibited medication

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2,1]
C0683610
UMLS CUI [2,2]
C0013227

Ähnliche Modelle

Eligibility Asthma NCT00766090

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00766090
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
asthma
Item
clinical diagnosis of asthma
boolean
C0004096 (UMLS CUI [1])
fev1 reversibility after albuterol
Item
reversibility ≥ 12% and ≥200mls reversibility of fev1 within approximately 30-minutes following 2 to 4 puffs of albuterol
boolean
C0748133 (UMLS CUI [1,1])
C0449261 (UMLS CUI [1,2])
C0001927 (UMLS CUI [2])
fev1
Item
fev1 between 40-85% predicted
boolean
C0748133 (UMLS CUI [1])
short-acting beta-2 agonist
Item
currently on short acting beta2 agonist therapy
boolean
C1373132 (UMLS CUI [1])
exclusion criteria
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
history of life threatening asthma
Item
history of life threatening asthma
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
respiratory infection or oropharyngeal candidiasis
Item
respiratory infection or oropharyngeal candidiasis
boolean
C0035243 (UMLS CUI [1])
C0919659 (UMLS CUI [2])
asthma exacerbation
Item
asthma exacerbation
boolean
C0349790 (UMLS CUI [1])
comorbidity
Item
uncontrolled disease or clinical abnormality
boolean
C0009488 (UMLS CUI [1])
allergies
Item
allergies
boolean
C0020517 (UMLS CUI [1])
another investigational medications or other prohibited medication
Item
taking another investigational medications or other prohibited medications
boolean
C0013230 (UMLS CUI [1])
C0683610 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video